Mark Velleca – Biography
Last update: December 15, 2025Executive profile
Mark was Chief Executive Officer at StrideBio, and Chief Executive Officer at G1 Therapeutics. Mark Velleca joined Black Diamond Therapeutics in 2025. Mark served as Director and Chairman of the Board for Black Diamond Therapeutics.
Mark Velleca is currentlyChief Executive Officer and Director at Black Diamond Therapeutics - View - Black Diamond Therapeutics org chart
Chairman of the Board at iOnctura - View - iOnctura org chart
Executive Chairman of the Board at CREATE Medicines - View - CREATE Medicines org chart
Create your alert
to follow the career of Mark Velleca.
Education
Mark Velleca has a Bachelor of Science from Yale University and a PhD from Washington University.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at Washington University :
Find more alumni from Washington University
More about Mark Velleca
Selected links
Do you need to know more about Mark Velleca? More results.
Participate
Social media
- Mark Velleca on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Velleca
The colleagues of Mark Velleca
Company Colleagues
- At Black Diamond Therapeutics, Mark Velleca has 21 colleagues including Garry Menzel (Director), Shannon Campbell (Director)…
- At iOnctura, Mark Velleca has 16 colleagues including Catherine Pickering (CEO & Director), Thijs Tervaert (Director)…
- At CREATE Medicines, Mark Velleca has 18 colleagues including Daniel Getts (CEO & Director), Brett Kaplan (Director)…
Industry Colleagues
- In the Biotechnology industry, Mark Velleca has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mark Velleca.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mark Velleca.
